Baylor Scott & White Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Baylor Scott & White Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9428
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Baylor Scott & White Health (Baylor Scott & White) is a not-for-profit healthcare service provider that offers medical care services. The organization offers medical education, medical services and conducts medical research. It offers medical services in the areas of emergency care, cancer care, behavioral and psychological health, heart health, breast care, body composition analysis, cholesterol, blood pressure, pediatric care and primary care, among others. The organization conducts its research through various institutes and centers. It operates through its hospitals and patient care sites across the US. Baylor Scott & White is headquartered in Dallas, Texas, the US.

Baylor Scott & White Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11
Baylor Scott & White Health Forms Joint Venture with AccentCare 12
Abzena and Baylor Scott & White Research Institute Form Joint Venture 13
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14
TGen Enters into Research Agreement with Baylor Research Institute 15
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17
Licensing Agreements 19
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19
Baylor Scott & White Health – Key Competitors 21
Baylor Scott & White Health – Key Employees 22
Baylor Scott & White Health – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Apr 10, 2017: Baylor Scott & White Health Opening Austin-Area Westlake Clinic 25
Mar 30, 2017: Baylor Scott & White Health Convenient Care Clinics to Open across Dallas-Fort Worth Area in Tom Thumb Stores 26
Mar 29, 2017: Baylor Scott & White Health Opening Kyle, Texas, Clinic 27
Feb 22, 2017: Baylor Scott & White Health Opens Cancer Center in College Station 28
Feb 08, 2017: Baylor Scott & White Health Increasing Health and Wellness Options with New Medical Center in Pflugerville 29
Jan 17, 2017: Baylor Scott & White Health Opening Austin-Area Primary Care Clinics, Offering App-Based Care Delivery Downtown 30
Jan 04, 2017: New Retail Pharmacy Opens Inside the Baylor Scott & White Medical Center – College Station 31
Corporate Communications 32
Mar 12, 2018: Baylor Scott And White Medical Center Frisco Announces New CEO 32
Nov 07, 2017: Baylor Scott & White Health Strengthens Executive Leadership Team with New Hire and Promotions 33
Legal and Regulatory 34
Jan 13, 2017: Baylor Scott & White Charles A. Sammons Cancer Center – McKinney Accredited by the Commission on Cancer of the American College of Surgeons 34
Government and Public Interest 35
Mar 29, 2017: Study Identifies Gene Mutation that Boosts Aspirin’s Cancer Prevention Benefits 35
Mar 06, 2017: New Colon Cancer Biomarkers May Guide Development of Personalized Treatment 36
Feb 13, 2017: Dallas Researchers Identify How Common Gut Bacteria May Cause Colon Cancer 37
Product News 38
Mar 03, 2017: Baylor Scott White Health Introduces Robotic-Assisted Cardiac Catheterization Technology to DFW 38
Other Significant Developments 39
Mar 22, 2018: Blue Cross and Blue Shield of Texas, Baylor Scott & White Health Announce New Agreement That Will Expand Access to Care 39
Jul 13, 2017: Baylor Scott & White Health Selects Kyruus’ Solutions to Enhance Provider Data Management and Patient Access 40
Mar 28, 2017: The Heart Hospital Baylor Plano Performs First Robotic-Assisted Peripheral Intervention in Texas 41
Mar 13, 2017: Baylor Scott & White Cancer Center – College Station Brings Care Where it’s Needed Most 42
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Key Facts 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Baylor Scott & White Health, Deals By Therapy Area, 2012 to YTD 2018 9
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 11
Baylor Scott & White Health Forms Joint Venture with AccentCare 12
Abzena and Baylor Scott & White Research Institute Form Joint Venture 13
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 14
TGen Enters into Research Agreement with Baylor Research Institute 15
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 16
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 17
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 19
Baylor Scott & White Health, Key Competitors 21
Baylor Scott & White Health, Key Employees 22
Baylor Scott & White Health, Subsidiaries 24

List of Figures
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Baylor Scott & White Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ardelyx Inc (ARDX):企業の財務・戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company offers products such as tenapanor, and RDX013. Its products are used for hyperphosphatemia in patients with end-stage renal disease; consti …
  • Canadian Natural Resources, Ltd.:企業の戦略・SWOT・財務情報
    Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ggp Inc:企業の戦略・SWOT・財務分析
    Ggp Inc - Strategy, SWOT and Corporate Finance Report Summary Ggp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Coeur Mining Inc:企業の戦略・SWOT・財務分析
    Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Entersoft SA (ENTER):企業の財務・戦略的SWOT分析
    Entersoft SA (ENTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • Academia Sinica:製薬・医療:M&Aディール及び事業提携情報
    Summary Academia Sinica is an academic institution that promotes and undertakes research activities in the disciplines of mathematics and physical sciences, life sciences, humanities and social sciences, and others. The institution integrates research activities to improve the planning, implementati …
  • Eindec Corporation Ltd (42Z):企業の財務・戦略的SWOT分析
    Eindec Corporation Ltd (42Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Air Liquide SA (AI):企業の財務・戦略的SWOT分析
    Air Liquide SA (AI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Aviva plc:企業のM&A・事業提携・投資動向
    Aviva plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aviva plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pengrowth Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pengrowth Energy Corp (Pengrowth) is an oil and gas company that explores, acquires, develops and produces oil and natural gas reserves. The company's services include development of large accu …
  • Saudi Basic Industries Corp (2010):企業の財務・戦略的SWOT分析
    Saudi Basic Industries Corp (2010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • BFS Group Limited:企業の戦略・SWOT・財務情報
    BFS Group Limited - Strategy, SWOT and Corporate Finance Report Summary BFS Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Hartford Financial Services Group, Inc.:企業のM&A・事業提携・投資動向
    The Hartford Financial Services Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hartford Financial Services Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • PATRIZIA Immobilien AG:企業のM&A・事業提携・投資動向
    PATRIZIA Immobilien AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PATRIZIA Immobilien AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Berli Jucker Public Co Ltd:企業の戦略・SWOT・財務情報
    Berli Jucker Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Berli Jucker Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alltech Inc:企業の戦略的SWOT分析
    Alltech Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CNX Resources Corp (CNX):石油・ガス:M&Aディール及び事業提携情報
    Summary CNX Resources Corporation (CNX Resources), formerly CONSOL Energy Inc., is an independent oil and natural gas company. It carries out the exploration, development, production, gathering, processing and acquisition of natural gas properties in the Appalachian Basin. The company has interests …
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆